Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 2
1975 1
1980 3
1983 1
1985 1
1986 4
1987 3
1988 3
1989 2
1990 8
1991 1
1993 1
1994 2
1996 2
1997 1
1999 1
2002 1
2003 5
2005 3
2006 2
2007 1
2008 5
2009 2
2010 4
2011 6
2012 6
2013 5
2014 5
2015 5
2016 4
2017 2
2018 3
2019 2
2020 7
2021 5
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Results by year
Filters applied: . Clear all
Page 1
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.
Motzer RJ, Hutson TE, Cella D, Reeves J, Hawkins R, Guo J, Nathan P, Staehler M, de Souza P, Merchan JR, Boleti E, Fife K, Jin J, Jones R, Uemura H, De Giorgi U, Harmenberg U, Wang J, Sternberg CN, Deen K, McCann L, Hackshaw MD, Crescenzo R, Pandite LN, Choueiri TK. Motzer RJ, et al. Among authors: merchan jr. N Engl J Med. 2013 Aug 22;369(8):722-31. doi: 10.1056/NEJMoa1303989. N Engl J Med. 2013. PMID: 23964934 Free article. Clinical Trial.
EV-101: A Phase I Study of Single-Agent Enfortumab Vedotin in Patients With Nectin-4-Positive Solid Tumors, Including Metastatic Urothelial Carcinoma.
Rosenberg J, Sridhar SS, Zhang J, Smith D, Ruether D, Flaig TW, Baranda J, Lang J, Plimack ER, Sangha R, Heath EI, Merchan J, Quinn DI, Srinivas S, Milowsky M, Wu C, Gartner EM, Zuo P, Melhem-Bertrandt A, Petrylak DP. Rosenberg J, et al. Among authors: merchan j. J Clin Oncol. 2020 Apr 1;38(10):1041-1049. doi: 10.1200/JCO.19.02044. Epub 2020 Feb 7. J Clin Oncol. 2020. PMID: 32031899 Free PMC article. Clinical Trial.
Axitinib plus pembrolizumab in patients with advanced sarcomas including alveolar soft-part sarcoma: a single-centre, single-arm, phase 2 trial.
Wilky BA, Trucco MM, Subhawong TK, Florou V, Park W, Kwon D, Wieder ED, Kolonias D, Rosenberg AE, Kerr DA, Sfakianaki E, Foley M, Merchan JR, Komanduri KV, Trent JC. Wilky BA, et al. Among authors: merchan jr. Lancet Oncol. 2019 Jun;20(6):837-848. doi: 10.1016/S1470-2045(19)30153-6. Epub 2019 May 8. Lancet Oncol. 2019. PMID: 31078463 Clinical Trial.
Antiangiogenic property of human thrombin.
Chan B, Merchan JR, Kale S, Sukhatme VP. Chan B, et al. Among authors: merchan jr. Microvasc Res. 2003 Jul;66(1):1-14. doi: 10.1016/s0026-2862(03)00037-2. Microvasc Res. 2003. PMID: 12826069 Review.
Antiangiogenic activity of 2-deoxy-D-glucose.
Merchan JR, Kovács K, Railsback JW, Kurtoglu M, Jing Y, Piña Y, Gao N, Murray TG, Lehrman MA, Lampidis TJ. Merchan JR, et al. PLoS One. 2010 Oct 27;5(10):e13699. doi: 10.1371/journal.pone.0013699. PLoS One. 2010. PMID: 21060881 Free PMC article.
Renal cancer: molecular mechanisms and newer therapeutic options.
Karumanchi SA, Merchan J, Sukhatme VP. Karumanchi SA, et al. Among authors: merchan j. Curr Opin Nephrol Hypertens. 2002 Jan;11(1):37-42. doi: 10.1097/00041552-200201000-00006. Curr Opin Nephrol Hypertens. 2002. PMID: 11753085 Review.
Outcomes of metastatic urothelial carcinoma following discontinuation of enfortumab-vedotin.
Curran C, Adib E, Kazakova V, Grivas P, Diamantopoulos LN, Alva AS, Su C, Jain RK, Tandon A, Necchi A, Marandino L, Plastini TM, Merchan JR, Sonpavde G. Curran C, et al. Among authors: merchan jr. Clin Genitourin Cancer. 2021 Aug 14:S1558-7673(21)00159-2. doi: 10.1016/j.clgc.2021.08.002. Online ahead of print. Clin Genitourin Cancer. 2021. PMID: 34503934
103 results